Skip to main content

Nicotine Polacrilex

NDC 45802-089 · Padagis Israel Pharmaceuticals Ltd

Generic nameNicotine Polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength2 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

45802-089-02 — 3 CONTAINER in 1 CARTON (45802-089-02) / 27 LOZENGE in 1 CONTAINER (45802-089-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43598-486 — Nicotine Polacrilex, 43598-487 — Nicotine Polacrilex, 43598-488 — Nicotine Polacrilex, 43598-489 — Nicotine Polacrilex, 43598-982 — Nicotine Polacrilex, 43598-983 — Nicotine Polacrilex, 43598-984 — Nicotine Polacrilex, 43598-985 — Nicotine Polacrilex, 43598-986 — Nicotine Polacrilex Lozenge 2 mg, 43598-987 — Nicotine Polacrilex Lozenge 4 mg, 45802-344 — Nicotine Polacrilex, 45802-651 — nicotine polacrilex, 45802-827 — nicotine polacrilex, 45802-873 — Nicotine Polacrilex, 45802-957 — Nicotine Polacrilex, 46122-352 — Nicotine Transdermal System, 46122-353 — Nicotine Transdermal System, 46122-354 — Nicotine Transdermal System, 46122-448 — Nicotine Polacrilex, 46122-449 — Nicotine Polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels